An advocacy victory: final USPSTF cervical cancer screening recommendations revised to include cotesting option

Diane Davis Davey, Robert A. Goulart, Ritu Nayar

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The recent reversal of the US Preventive Services Task Force decision to drop cotesting (Papicolaou test + high-risk human papillomavirus test) as an option for cervical cancer screening in women aged 30 to 65 years from their recommendations for cervical cancer screening was directly attributed to advocacy efforts by professional organizations and individuals. This communication summarizes the pathology and laboratory medicine community's role in this advocacy effort by collaboration of all major US Pathology organizations, via the Cytopathology Education and Technology consortium.

Original languageEnglish (US)
Pages (from-to)333-335
Number of pages3
JournalJournal of the American Society of Cytopathology
Volume7
Issue number6
DOIs
StatePublished - Nov 1 2018

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Pathology
Advisory Committees
Medicine
Organizations
Technology
Education

Keywords

  • Cervical cancer
  • Cervical cancer screening
  • Cervical cytology
  • Pap test
  • Primary HPV screening
  • USPSTF guidelines

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{51430d1ff7ad4204af661a3d08d3520c,
title = "An advocacy victory: final USPSTF cervical cancer screening recommendations revised to include cotesting option",
abstract = "The recent reversal of the US Preventive Services Task Force decision to drop cotesting (Papicolaou test + high-risk human papillomavirus test) as an option for cervical cancer screening in women aged 30 to 65 years from their recommendations for cervical cancer screening was directly attributed to advocacy efforts by professional organizations and individuals. This communication summarizes the pathology and laboratory medicine community's role in this advocacy effort by collaboration of all major US Pathology organizations, via the Cytopathology Education and Technology consortium.",
keywords = "Cervical cancer, Cervical cancer screening, Cervical cytology, Pap test, Primary HPV screening, USPSTF guidelines",
author = "Davey, {Diane Davis} and Goulart, {Robert A.} and Ritu Nayar",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.jasc.2018.08.005",
language = "English (US)",
volume = "7",
pages = "333--335",
journal = "Journal of the American Society of Cytopathology",
issn = "2213-2945",
publisher = "Elsevier BV",
number = "6",

}

An advocacy victory : final USPSTF cervical cancer screening recommendations revised to include cotesting option. / Davey, Diane Davis; Goulart, Robert A.; Nayar, Ritu.

In: Journal of the American Society of Cytopathology, Vol. 7, No. 6, 01.11.2018, p. 333-335.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An advocacy victory

T2 - final USPSTF cervical cancer screening recommendations revised to include cotesting option

AU - Davey, Diane Davis

AU - Goulart, Robert A.

AU - Nayar, Ritu

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The recent reversal of the US Preventive Services Task Force decision to drop cotesting (Papicolaou test + high-risk human papillomavirus test) as an option for cervical cancer screening in women aged 30 to 65 years from their recommendations for cervical cancer screening was directly attributed to advocacy efforts by professional organizations and individuals. This communication summarizes the pathology and laboratory medicine community's role in this advocacy effort by collaboration of all major US Pathology organizations, via the Cytopathology Education and Technology consortium.

AB - The recent reversal of the US Preventive Services Task Force decision to drop cotesting (Papicolaou test + high-risk human papillomavirus test) as an option for cervical cancer screening in women aged 30 to 65 years from their recommendations for cervical cancer screening was directly attributed to advocacy efforts by professional organizations and individuals. This communication summarizes the pathology and laboratory medicine community's role in this advocacy effort by collaboration of all major US Pathology organizations, via the Cytopathology Education and Technology consortium.

KW - Cervical cancer

KW - Cervical cancer screening

KW - Cervical cytology

KW - Pap test

KW - Primary HPV screening

KW - USPSTF guidelines

UR - http://www.scopus.com/inward/record.url?scp=85054027396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054027396&partnerID=8YFLogxK

U2 - 10.1016/j.jasc.2018.08.005

DO - 10.1016/j.jasc.2018.08.005

M3 - Article

VL - 7

SP - 333

EP - 335

JO - Journal of the American Society of Cytopathology

JF - Journal of the American Society of Cytopathology

SN - 2213-2945

IS - 6

ER -